8-K current report · filed Jul 30, 2026

Penumbra Inc (PEN) 8-K Current Report: July 30, 2026

Item 2.02Item EX-99.1PEN overview

Short answer

Penumbra Inc (PEN) filed an 8-K current report with the SEC on July 30, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 fiscal 2026 results for quarter ended June 30, 2026.

Penumbra Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q2 fiscal 2026 results for quarter ended June 30, 2026
  • Penumbra’s earnings press release furnished as Exhibit 99.1
  • Investor focus: revenue, profitability, guidance and product trends in the accompanying release

Item EX-99.1 · Exhibit EX-99.1

  • Q2 revenue $390.0M, up 14.9%, with U.S. growth 17.1% outpacing international growth 7.6%
  • Embolization and Access revenue $131.1M, up 20.0%, outpacing thrombectomy revenue growth of 12.5%
  • Gross margin 67.9%, up 1.9 percentage points, while operating expenses rose to $223.9M
  • Net income $34.8M, down from $45.3M, reflecting income tax expense of $11.4M versus $0.04M
  • Pending Boston Scientific acquisition limits visibility: no full-year 2026 guidance or earnings conference call; $6.9M acquisition-related expenses incurred in SG&A

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Penumbra Inc 8-K filings

Get the next PEN 8-K as it lands

Follow PEN for push alerts, or ask the research agent what this filing means.